Heather Gangemi
About Heather Gangemi
Heather Gangemi is a Scientist at Bristol-Myers Squibb in New Jersey, United States, with expertise in Human Error Investigations and technical transfers of new products.
Title and Current Role
Heather Gangemi is currently a Scientist at Bristol-Myers Squibb in New Jersey, United States. In this role, she designs and executes studies to demonstrate new technology and assists with technical transfers of new products. Additionally, she serves as a site trainer and coach for the Investigation Process, reflecting her expertise in Human Error Investigations.
Previous Roles at Bristol-Myers Squibb
Heather previously held roles at Bristol-Myers Squibb as a Downstream Process Operator from 2008 to 2010 and as a Purification Process Operator from 2004 to 2008, both in New Jersey, United States. These positions provided her with extensive experience in downstream and purification processes, building a foundation for her current scientific work.
Education Background
Heather Gangemi earned her Bachelor of Science in Physics from Le Moyne College, where she studied from 2000 to 2004. Prior to her college education, she attended Cicero - North Syracuse High School. Her academic background in physics supports her technical prowess and understanding of complex scientific principles in her current role.
Human Error Investigation Expertise
Heather's role as a site trainer and coach for the Investigation Process at Bristol-Myers Squibb highlights her specialization in Human Error Investigations. Her responsibilities include training colleagues and guiding investigations to improve processes and reduce errors. This expertise is vital in ensuring the accuracy and reliability of operational procedures within the company.
Technical Transfer and New Technology
In her capacity as a Scientist, Heather designs and executes studies demonstrating new technology and assists in the technical transfer of new products at Bristol-Myers Squibb. Her work ensures that innovations are effectively integrated into production, thus enhancing efficiency and functionality of new biopharmaceutical solutions.